09October

bluebird bio and Novo Nordisk enter into research agreement to develop in vivo g ... Read more

01October

Novo Nordisk and Noom to partner around digital health solutions to help people ... Read more

20September

Rybelsus® (semaglutide tablets), the first GLP-1 in a tablet approved in the US ... Read more

16September

Medtronic and Novo Nordisk enter agreement to provide integrated digital solutio ... Read more

14October

Novo Nordisk A/S – Share repurchase programme ... Read more

07October

Novo Nordisk A/S – Share repurchase programme ... Read more

30September

Novo Nordisk A/S – Share repurchase programme ... Read more

23September

Novo Nordisk A/S – Share repurchase programme ... Read more

01November

Financial statement for the first nine months of 2019,

01January

Silent period ,

01October

Silent period,

17September

Handelsbanken Nordic Blue Chip Seminar , Stockholm

 

 

 

Investors

Share information
 

Corporate reporting

Private shareholders


Shareholder tools and systems for private investors

 

Investor materials

Contact Investor Relations

Sign-up: Company announcements


Sign up and receive our company announcements

 

Financial results and events overview

SHARE Magazine


Get the latest SHARE Magazine
- news for you as an investor

Capital markets day


Invitation to CMD 2019
- Invitation page and registration

Rybelsus® US approval

 



Access conference call
- Webcast and presentation